Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,742 | -30,801 | -19,512 | -10,012 | -35,087 |
| Depreciation Amortization | 1,861 | 1,085 | 548 | 266 | 322 |
| Other Working Capital | -2,011 | -1,589 | -1,820 | 272 | 881 |
| Other Operating Activity | 4,943 | 3,663 | 2,392 | 1,173 | 4,007 |
| Operating Cash Flow | $-36,949 | $-27,642 | $-18,392 | $-8,301 | $-29,877 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194 | -110 | -110 | -93 | -607 |
| Purchase Of Investment | -225,728 | -182,667 | -143,780 | -72,518 | -102,255 |
| Sale Of Investment | 169,424 | 108,961 | 67,284 | 33,281 | 123,281 |
| Investing Cash Flow | $-56,498 | $-73,816 | $-76,606 | $-39,330 | $20,419 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 99,642 | 99,325 | 97,363 | 53,368 | 272 |
| Financing Cash Flow | $99,642 | $99,325 | $97,363 | $53,368 | $272 |
| Exchange Rate Effect | 82 | 15 | -20 | -117 | -45 |
| Beginning Cash Position | 14,951 | 14,951 | 14,951 | 14,951 | 24,182 |
| End Cash Position | 21,228 | 12,833 | 17,296 | 20,571 | 14,951 |
| Net Cash Flow | $6,277 | $-2,118 | $2,345 | $5,620 | $-9,231 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,949 | -27,642 | -18,392 | -8,301 | -29,877 |
| Capital Expenditure | -194 | -110 | -110 | -93 | -607 |
| Free Cash Flow | -37,143 | -27,752 | -18,502 | -8,394 | -30,484 |